Texas Transvaginal Surgical Mesh Lawyers
FDA WARNING: Transvaginal Surgical Mesh May Cause Serious Complications
On October 20, 2008, the Food and Drug Administration (FDA) issued a Public Health Notification warning consumers and health practitioners about serious complications associated with transvaginal placement of surgical mesh used to treat Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI)
If you were injured by Transvaginal Surgical Mesh complications contact the law firm of Van Wey & Johnson, LLP today.
The FDA stated that over the last three years, it had received more than 1,000 reports from nine surgical mesh manufacturers of complications that were associated with surgical mesh devices used to repair POP and SUI. Typically, these surgical mesh devices are placed transvaginally (through the vaginal wall) using a minimally-invasive procedure.
The transvaginal surgical mesh complications most frequently reported to the FDA included:
- erosion through vaginal epithelium
- infection
- Pain
- urinary problems
- recurrence of prolapse and/or incontinence
Additionally, the FDA received reports of bowel, bladder, and blood vessel perforation which occurred during insertion of the transvaginal surgical mesh. In some cases, discomfort and pain (including dyspareunia) from vaginal scarring and surgical mesh erosion led to a significant decrease in patient quality of life.
Treatment of the various types of complications associated with transvaginal placement of surgical mesh may require additional surgical procedures (some of them to remove the transvaginal mesh), IV therapy, blood transfusions, and drainage of hematomas or abscesses.
If you or a loved one has experienced the painful complications associated with transvaginal placement of surgical mesh, including Avaulta surgical mesh, you may be entitled to compensation for your injuries. Contact Van Wey & Johnson, LLP today for a confidential and free case evaluation.
